Sandbox:Roukoz: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 1: Line 1:
{{familytree/start |summary= Algorithm for diagnosis of CUP}}
{{familytree/start |summary= Algorithm for diagnosis of CUP}}
{{familytree | | | | | | | | | | A01 | | | | | | |A01=Tumor of unknown primary origin}}
{{familytree | | | | | | | | | | | A01 | | | | | | |A01=Tumor of unknown primary origin}}
{{familytree | | | | | | | | | | |!| | | | | | | | |}}
{{familytree | | | | | | | | | | | |!| | | | | | | | |}}
{{familytree | | | | | | | | | |boxstyle=text-align: left; | B01 | | | | | | |B01= • Full medical history and physical exam<br> • Basic blood and bichemical analysis<br> • CT scan of chest, abdomen, and pelvis}}
{{familytree | | | | | | | | | | |boxstyle=text-align: left; | B01 | | | | | | |B01= • Full medical history and physical exam<br> • Basic blood and bichemical analysis<br> • CT scan of chest, abdomen, and pelvis}}
{{familytree | | | | | | | | | | |!| | | | | | | | | }}
{{familytree | | | | | | | | | | | |!| | | | | | | | | }}
{{familytree | | | | | | | | | | C01 | | | | | | |C01=Histopathologic examination}}
{{familytree | | | | | | | | | | | C01 | | | | | | |C01=Histopathologic examination}}
{{familytree | | | |,|-|-|-|-|-|-|^|v|-|-|-|-|-|.| | }}
{{familytree | | | | |,|-|-|-|-|-|-|^|v|-|-|-|-|-|.| | }}
{{familytree | | |D01| | | | | | |D02| | | D03 | |D01='''Squamous cell carcinoma'''|D02='''Neuroendocrine carcinoma'''|D03='''Adenocarcinoma and poorly differntiated carcinoma'''}}
{{familytree | | | |D01| | | | | | |D02| | | D03 | |D01='''Squamous cell carcinoma'''|D02='''Neuroendocrine carcinoma'''|D03='''Adenocarcinoma and poorly differntiated carcinoma'''}}
{{familytree | | | |!| | | | | | | |!| | | | | |!| | }}
{{familytree | | | | |!| | | | | | | |!| | | | | |!| | }}
{{familytree | | | E01 | | | | | | E02 | | | | E03 | | |E01=Additional tests specific to location of metastasis|E02=• Octreoscan<br> • Plasma chromogranin A|E03=Gender specific tests}}
{{familytree | | | | E01 | | | | | | E02 | | | | E03 | | |E01=Additional tests specific to location of metastasis|E02=• Octreoscan<br> • Plasma chromogranin A|E03=Gender specific tests}}
{{familytree | | | |!| | | | | | | | | | | | |!| | | }}
{{familytree | | | | |!| | | | | | | | | | | | |!| | | }}
{{familytree | |,|-|+|-|.| | | | | | | | |,|-|^|-|.| | }}
{{familytree | | |,|-|+|-|.| | | | | | | | |,|-|^|-|.| | }}
{{familytree |F01| |F02| |F03| | | | | | | | | |F04| | |F05| | |F01=bone|F02=Ing|F03=Supra}}
{{familytree |F01| |F02| |F03| | | | | | | | | | |F04| | |F05| | |F01=bone|F02=Ing|F03=Supra}}
{{familytree/end}}
{{familytree/end}}

Revision as of 19:25, 10 October 2018

 
 
 
 
 
 
 
 
 
 
Tumor of unknown primary origin
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
• Full medical history and physical exam
• Basic blood and bichemical analysis
• CT scan of chest, abdomen, and pelvis
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Histopathologic examination
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Squamous cell carcinoma
 
 
 
 
 
 
Neuroendocrine carcinoma
 
 
Adenocarcinoma and poorly differntiated carcinoma
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Additional tests specific to location of metastasis
 
 
 
 
 
• Octreoscan
• Plasma chromogranin A
 
 
 
Gender specific tests
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
bone
 
Ing
 
Supra
 
 
 
 
 
 
 
 
 
 
{{{F04}}}
 
 
{{{F05}}}